Litcius/Paper detail

LBA3 Final analysis of the phase III KEYNOTE-585 study of pembrolizumab plus chemotherapy vs chemotherapy as perioperative therapy in locally-advanced gastric and gastroesophageal junction cancer

Kohei Shitara, Sun Young Rha, Lucjan Wyrwicz, Takashi Oshima, Nina Karaseva, M. A. Osipov, Haruna Yasui, Hiroshi Yabusaki, S. G. Afanasyev, Park Yk, S-E. Al-Batran, Takaki Yoshikawa, P.E. Yanez Weber, Maria Di Bartolomeo, Sara Lonardi, X. Fang, C-S. Shih, P. Bhagia, Y-J. Bang

2024Annals of Oncology13 citationsDOIOpen Access PDF

Topics & Concepts

MedicinePembrolizumabChemotherapyCancerPerioperativeGastroesophageal JunctionInternal medicineOncologySurgeryAdenocarcinomaImmunotherapyCancer Immunotherapy and BiomarkersGastric Cancer Management and OutcomesEsophageal Cancer Research and Treatment
LBA3 Final analysis of the phase III KEYNOTE-585 study of pembrolizumab plus chemotherapy vs chemotherapy as perioperative therapy in locally-advanced gastric and gastroesophageal junction cancer | Litcius